Table 5.
S. No. | Structures of metabolites | Side Chains | Observed Peaks (m/z) | MS/MS (Verified)* | MS/MS (Reported) | References | ||
---|---|---|---|---|---|---|---|---|
N-acyl-homoserine lactones (AHLs) | [M + H]+ | [M−H]− | ||||||
m/z | Abundance* | |||||||
1 | C5:0-C5H11 | 200 | 2 | - | (+) 172, 156, 102, 88. | -** | 29 | |
C7:0 -C7H15 | 228 | 9 | - | (+) 214, 200, 102, 88, 70. | -** | 26,28 | ||
C9:0 -C9H19 | 256 | 3 | - | (+) 228, 212, 200, 102, 88. | -** | 26 | ||
C11:0-C11H23 | 284 | 9 | - | (+) 256, 240, 102, 88. | -** | 26 | ||
2 | C5:0 -C5H11 | 218 | 20 | - | (+) 200, 174, 156, 142, 116, 106, 102, 88, 70. | -** | 28 | |
C7:0 -C7H15 | 246 | 25 | - | (+) 228, 202, 184, 106, 102, 88. | -** | 28 | ||
C9:0-C9H19 | 274 | 100 | - | (+) 256, 230, 212, 106, 102, 88. | -** | 26 | ||
C11:0-C11H23 | 302 | 18 | - | (+) 284, 258, 240, 106, 102, 88. | -** | 26 | ||
C13:0 –C13H27 | 330 | 7 | - | (+) 312, 286, 268, 106, 102. | -** | 26 | ||
3 | C6:0 -C6H13O3*** | 262 | 13 | - | (+) 244, 200, 102, 88. | -** | Current study | |
C8:0-C8H17O3*** | 290 | 18 | - | (+) 272, 228, 102, 88. | -** | Current study | ||
C10:0-C10H21O3*** | 318 | 75 | - | (+) 300, 256, 102. | -** | Current study | ||
C12:0–C12H25O3*** | 346 | 12 | - | (+) 328, 284, 102, 88. | -** | Current study | ||
C14:0–C14H29O3*** | 374 | 5 | - | (+) 356, 312, 102. | -** | Current study | ||
4-hydroxy-2-Alkylquinolines (HAQs) | ||||||||
4 | C7:0–C7H15 | 244 | 22 | 242 |
(+) 226, 186, 172, 159, 146. (−) 228, 198, 170, 158, 158, 144, 143. |
(+) 200, 188, 186, 172, 159, 146. (+) 186, 172, 159, 146. |
27,50 | |
C8:0–C8H17 | 258 | 10 | - | (+) 244, 230, 226, 216, 202, 198, 188, 186, 184, 174, 172, 170, 162, 160, 159, 156, 146, 132. | (+) 240, 224, 198, 188, 186, 172, 159, 146. | 27,47 | ||
C9:0–C9H19 | 272 | 29 | 270 |
(+) 258, 254, 240, 226, 216, 202, 198, 188, 186, 172, 162, 160, 159, 146, 132. (−) 242, 226, 212, 198, 184, 170, 157. |
(+) 186, 172, 159, 146. (−) 184, 170, 158, 157, 144. (+) 184, 172, 159. |
27,34 | ||
5 | C8:1–C8H15 | 286 | 85 | 284 |
(+) 268, 258, 254, 244, 240, 230, 226, 216, 212, 202. (−) 270, 256, 240, 228, 186, 173, 159. |
(+) 268, 258, 240, 226, 216, 212, 202, 198, 188, 186, 184, 174, 172, 162, 160, 159, 146, 132. | 27,50 | |
6 | C7:0–C7H15 | 260 | 42 | 258 |
(+) 242, 228, 214, 200, 186, 175, 172, 162, 159. (−) 240, 230, 214, 186, 173, 159, 144. |
(+) 188, 175. (+) 242, 186, 175, 172, 162, 159. (−) 241, 240, 230, 214, 187, 173, 172, 159, 144. |
27,34 | |
Rhamnolipids | ||||||||
Mono-rhamno-di-lipidic congers | ||||||||
7 | Rha-C10-C10 | - | 100 | 503 | (−) 474, 362, 339, 334, 324, 306, 169. | -** | 51 | |
Rha-C10-C10 | - | 9 | 504 | (−) 361, 340, 169. | -** | 52 | ||
Di-rhamno-di-lipidic congers | ||||||||
8 | Rha-Rha-C10-C10 | - | 19 | 649 | (−) 479, 339. | -** | 51 | |
9 | Decenoyl-Rha-Rha-C10-C10 | 803 | 62 | - | (+) 301. | -** | 35 |